EP1381360A4 - Compounds and methods for inhibiting metap2 in mammals - Google Patents
Compounds and methods for inhibiting metap2 in mammalsInfo
- Publication number
- EP1381360A4 EP1381360A4 EP02723701A EP02723701A EP1381360A4 EP 1381360 A4 EP1381360 A4 EP 1381360A4 EP 02723701 A EP02723701 A EP 02723701A EP 02723701 A EP02723701 A EP 02723701A EP 1381360 A4 EP1381360 A4 EP 1381360A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- mammals
- compounds
- methods
- metap2
- inhibiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/30—Isothioureas
- C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27956301P | 2001-03-29 | 2001-03-29 | |
US279563P | 2001-03-29 | ||
PCT/US2002/009954 WO2002078697A1 (en) | 2001-03-29 | 2002-03-28 | Compounds and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1381360A1 EP1381360A1 (en) | 2004-01-21 |
EP1381360A4 true EP1381360A4 (en) | 2009-12-02 |
Family
ID=23069522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02723701A Withdrawn EP1381360A4 (en) | 2001-03-29 | 2002-03-28 | Compounds and methods for inhibiting metap2 in mammals |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1381360A4 (en) |
JP (1) | JP2005508841A (en) |
WO (1) | WO2002078697A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2858617A1 (en) * | 2003-08-06 | 2005-02-11 | Inst Nat Sante Rech Med | NOVEL 4 ', 4'-DITHIOBIS- (3-AMINOBUTANE-1-SULFONATE-1-SULFONATES) DERIVATIVES AND COMPOSITIONS CONTAINING SAME |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987001706A2 (en) * | 1985-09-12 | 1987-03-26 | The Upjohn Company | C20 through c26 amino steroids |
US5760246A (en) * | 1996-12-17 | 1998-06-02 | Biller; Scott A. | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
WO1998027092A1 (en) * | 1996-12-18 | 1998-06-25 | Sugen, Inc. | Thiazole compounds and methods of modulating signal transduction |
WO1998056372A1 (en) * | 1997-06-09 | 1998-12-17 | Massachusetts Institute Of Technology | TYPE 2 METHIONINE AMINOPEPTIDASE (MetAP2) INHIBITORS AND USES THEROF |
US5883110A (en) * | 1995-06-07 | 1999-03-16 | Sugen, Inc. | Pharmaceutical compositions and methods for modulating signal transduction |
WO1999032466A1 (en) * | 1997-12-22 | 1999-07-01 | Novartis Ag | Substituted benzenesulfonamide derivatives and their pharmaceutical use |
EP1044970A1 (en) * | 1999-04-15 | 2000-10-18 | Adir Et Compagnie | Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them |
DE19922443A1 (en) * | 1999-05-07 | 2000-11-09 | Basf Ag | Use of dopamine D3 receptor ligands in the manufacture of drugs for the treatment of renal dysfunction |
WO2001025220A1 (en) * | 1999-10-07 | 2001-04-12 | Amgen Inc. | Triazine kinase inhibitors |
WO2001024796A1 (en) * | 1999-10-01 | 2001-04-12 | Smithkline Beecham Corporation | 1,2,4-triazole derivatives, composition, process of making and methods of use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411980A (en) * | 1989-07-28 | 1995-05-02 | Merck & Co., Inc. | Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists |
US5177095A (en) * | 1990-02-13 | 1993-01-05 | Merck & Co., Inc. | Triazole angiotensin II antagonists incorporating a substituted benzyl element |
US5436259A (en) * | 1991-05-10 | 1995-07-25 | Merck & Co., Inc. | Substituted 1,2,4-triazolin-3-one compounds bearing acidic functional groups as balanced angiotensin II antagonists |
EP0710654A4 (en) * | 1993-07-23 | 1996-08-28 | Green Cross Corp | Triazole derivative and pharmaceutical use thereof |
US5489598A (en) * | 1994-06-08 | 1996-02-06 | Warner-Lambert Company | Cytoprotection utilizing aryltriazol-3-thiones |
-
2002
- 2002-03-28 EP EP02723701A patent/EP1381360A4/en not_active Withdrawn
- 2002-03-28 WO PCT/US2002/009954 patent/WO2002078697A1/en active Application Filing
- 2002-03-28 JP JP2002576963A patent/JP2005508841A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987001706A2 (en) * | 1985-09-12 | 1987-03-26 | The Upjohn Company | C20 through c26 amino steroids |
US5883110A (en) * | 1995-06-07 | 1999-03-16 | Sugen, Inc. | Pharmaceutical compositions and methods for modulating signal transduction |
US5760246A (en) * | 1996-12-17 | 1998-06-02 | Biller; Scott A. | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
WO1998027092A1 (en) * | 1996-12-18 | 1998-06-25 | Sugen, Inc. | Thiazole compounds and methods of modulating signal transduction |
WO1998056372A1 (en) * | 1997-06-09 | 1998-12-17 | Massachusetts Institute Of Technology | TYPE 2 METHIONINE AMINOPEPTIDASE (MetAP2) INHIBITORS AND USES THEROF |
WO1999032466A1 (en) * | 1997-12-22 | 1999-07-01 | Novartis Ag | Substituted benzenesulfonamide derivatives and their pharmaceutical use |
EP1044970A1 (en) * | 1999-04-15 | 2000-10-18 | Adir Et Compagnie | Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them |
DE19922443A1 (en) * | 1999-05-07 | 2000-11-09 | Basf Ag | Use of dopamine D3 receptor ligands in the manufacture of drugs for the treatment of renal dysfunction |
WO2001024796A1 (en) * | 1999-10-01 | 2001-04-12 | Smithkline Beecham Corporation | 1,2,4-triazole derivatives, composition, process of making and methods of use |
WO2001025220A1 (en) * | 1999-10-07 | 2001-04-12 | Amgen Inc. | Triazine kinase inhibitors |
Non-Patent Citations (3)
Title |
---|
DEMIRAYAK, SEREF ET AL: "Synthesis of some 3-arylamino-5-aryloxymethyl[1,2,4]triazole derivatives and their antimicrobial activity", PHARMACEUTICA ACTA HELVETIAE ( 1998 ), 72(5), 285-290 CODEN: PAHEAA; ISSN: 0031-6865, 1998, XP002551299 * |
FREDERICK KURZER AND K DOURAGHI-ZADEH: "HETEROCYCLIC COMPOUNDS FROM UREA DERIVATIVES. PART VI. SYNTHESIS AND CYCLISATION OF 1-AMINO-3-(NN-DIARYLAMIDINO)GUANIDINES AND SOME ANALOGUES", JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL SOCIETY, LETCHWORTH., GB, 1 January 1965 (1965-01-01), pages 932 - 937, XP009077698, ISSN: 0368-1769 * |
See also references of WO02078697A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1381360A1 (en) | 2004-01-21 |
JP2005508841A (en) | 2005-04-07 |
WO2002078697A1 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0318178D0 (en) | No Title | |
AU2002357119A8 (en) | Mitocidal compositions and methods | |
GB0305785D0 (en) | No title | |
EP1434772A4 (en) | Compounds and methods | |
AU2002350244A8 (en) | Pyridoquinoxaline antivirals | |
AU2002357748A8 (en) | Osteopontin-related compositions and methods | |
AU2002359694A8 (en) | Compounds and methods | |
GB0126251D0 (en) | Methods | |
GB0120042D0 (en) | Methods | |
AU2002359464A8 (en) | Angiopioetin related factors | |
GB0302096D0 (en) | No Title | |
GB0114626D0 (en) | Barrier Arrangements | |
EP1379240A4 (en) | Compounds and methods | |
EP1381360A4 (en) | Compounds and methods for inhibiting metap2 in mammals | |
GB0220398D0 (en) | An osteoprosthesis component | |
GB0310601D0 (en) | No title | |
GB0203655D0 (en) | No title | |
AU2002359869A8 (en) | Pak5-related compositions and methods | |
GB0125319D0 (en) | Improved protective films | |
GB0107030D0 (en) | Personal locator | |
GB2374899B (en) | Stays | |
TW525451U (en) | Rail component | |
HUP0202901A2 (en) | Modified based metathese-catalyzers | |
PL112552U1 (en) | Multimedia caisson | |
GB0103643D0 (en) | Improvements in protecting filis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20031020 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 35/00 20060101ALI20091022BHEP Ipc: C07D 409/12 20060101ALI20091022BHEP Ipc: C07D 409/06 20060101ALI20091022BHEP Ipc: C07D 401/04 20060101ALI20091022BHEP Ipc: C07D 333/24 20060101ALI20091022BHEP Ipc: C07D 249/14 20060101ALI20091022BHEP Ipc: A61K 31/41 20060101AFI20021014BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20091030 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20091001 |